Literature DB >> 19633523

Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.

H Simon Schaaf1, Marianne Willemse, Peter R Donald.   

Abstract

Treatment of extensively drug-resistant tuberculosis (XDR-TB) is a challenge. We describe a young child with pulmonary XDR-TB who did not respond to an aggressive multidrug-resistant TB treatment regimen, but was cured with linezolid in combination with other reserve antituberculous drugs. No serious adverse events were observed during 19 months of treatment for XDR-TB.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19633523     DOI： 10.1097/INF.0b013e31819bc491

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  6 in total

1.  Use of linezolid in neonatal and pediatric inpatient facilities--results of a retrospective multicenter survey.

Authors:  A Simon; E Müllenborn; M Prelog; W Schenk; J Holzapfel; F Ebinger; A Klabunde-Cherwon; J Faber; A H Groll; K Masjosthusmann; C Dohna-Schwake; K Beutel; E Dirkwinkel; T Lehrnbecher; R A Ammann; A Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-03       Impact factor: 3.267

Review 2.  Nervous system effects of antituberculosis therapy.

Authors:  Joseph S Kass; Wayne X Shandera
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

3.  Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa.

Authors:  T A Thomas; S V Shenoi; S K Heysell; F J Eksteen; V B Sunkari; N R Gandhi; G Friedland; N S Shah
Journal:  Int J Tuberc Lung Dis       Date:  2010-10       Impact factor: 2.373

4.  Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs.

Authors:  Tea Madzgharashvili; Argita D Salindri; Matthew J Magee; Nestani Tukvadze; Zaza Avaliani; Henry M Blumberg; Russell R Kempker; Nino Lomtadze
Journal:  J Pediatric Infect Dis Soc       Date:  2021-04-30       Impact factor: 3.164

5.  The spread of drug-resistant tuberculosis in children: an Italian case series.

Authors:  F Mignone; L R Codecasa; C Scolfaro; I Raffaldi; L Lancella; M Ferrarese; S Garazzino; C Marabotto; S Esposito; C Gabiano; R Lipreri; P-A Tovo
Journal:  Epidemiol Infect       Date:  2013-12-19       Impact factor: 4.434

6.  Filgrastim therapy in a child with neutropenia induced by linezolid.

Authors:  Marta Hernández Segurado; Maria Ángeles Arias Moya; Marta Gómez Pérez; Macarena Bonilla Porras; Eva Castillo Bazán; Francisco Javier Bécares Martínez; Gema Toledano Mayoral; María Isabel Panadero Esteban
Journal:  Int J Clin Pharm       Date:  2013-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.